Vse Corp (VSEC) Stock Price & Analysis
Vse Corp (VSEC) rose 4.08% to USD 178.62 as of June 10, 2026 at 02:24 UTC, according to Nexqual real-time market data.
VSEC last closed at USD 171.62; the session ranged USD 167.96–180 on volume of 453,856 shares. Market capitalization is $5.01B, with a 52-week range of USD 123.69–232.61 (NMS). Source: Nexqual, June 10, 2026 at 02:24 UTC.
Key Statistics (as of June 10, 2026 at 02:24 UTC)
| Price | USD 178.62 |
|---|---|
| Change | ▲ 4.08% (up) |
| Previous Close | USD 171.62 |
| Open | USD 174.02 |
| Day Range | USD 167.96 – 180 |
| 52-Week Range | USD 123.69 – 232.61 |
| Volume | 453,856 shares |
| Market Cap | $5.01B |
| Exchange | NMS |
Technical Analysis (VSEC)
Nexqual's technical model rates VSEC "NEUTRAL" based on 2 bullish and 3 bearish signals across 124 daily candles, as of June 10, 2026 at 02:24 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.42 (neutral) |
| vs SMA50 | Below (USD 186.61) |
| MACD | -1.82 (negative) |
Analyst Ratings (VSEC)
Wall Street analysts rate VSEC "Strong Buy" based on 8 analysts, with a mean price target of USD 252.88 (range USD 230–270), per Nexqual as of June 10, 2026 at 02:24 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 8 |
| Mean Target | USD 252.88 |
| High Target | USD 270 |
| Low Target | USD 230 |
| Buy / Hold / Sell | 9 / 0 / 0 |
Earnings (VSEC)
| Next Earnings Date | 2026-07-29 |
|---|---|
| EPS Estimate | USD 0.92 |
| Revenue Estimate | $427.57M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 1.17 vs est 0.89 ▲ beat |
| 2025-12-31 | USD 1.16 vs est 0.89 ▲ beat |
| 2025-09-30 | USD 0.99 vs est 0.84 ▲ beat |
| 2025-06-30 | USD 0.97 vs est 0.7 ▲ beat |
Source: Nexqual, June 10, 2026 at 02:24 UTC.
Financials & Fundamentals (VSEC)
| Total Revenue | $1.18B |
|---|---|
| Revenue Growth (YoY) | +26.80% |
| Gross Margin | +14.67% |
| Operating Margin | +11.48% |
| Profit Margin | +4.21% |
| ROE | +3.77% |
| Debt / Equity | 15.11 |
| Current Ratio | 8.78 |
| Total Cash | $1.24B |
| Total Debt | $402.80M |
| Free Cash Flow | $110.19M |
Source: Nexqual, June 10, 2026 at 02:24 UTC.
Financial Health Score (VSEC)
Nexqual rates Vse Corp's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:24 UTC.
| Growth | Mixed — Revenue +3.0% YoY (annual), slow |
|---|---|
| Profitability | Weak — Gross margin 15%, operating 11% |
| Balance Sheet | Strong — $1.24B cash vs $403M debt, net cash position |
| Cash Flow | Solid — FCF $110M, 10% margin |
| Efficiency | Weak — ROE 4%, ROA 3.4% |
Ownership (VSEC)
| Insider Ownership | +1.80% |
|---|---|
| Institutional Ownership | +130.30% |
| Shares Outstanding | 28.06M |
| Float | 26.15M |
| Short % of Float | +8.24% |
Source: Nexqual, June 10, 2026 at 02:24 UTC.
Leadership (VSEC)
Vse Corp is led by John A. Cuomo (age 51), CEO, President & Director, per Nexqual as of June 10, 2026 at 02:24 UTC.
| CEO, President & Director | John A. Cuomo (age 51) |
|---|---|
| Chief Financial Officer | Adam Robert Cohn (age 38) |
| Chief Operating Officer | Benjamin E. Thomas (age 41) |
| Vice President of Investor Relations & Communications | Michael Perlman |
| Director of Operations - VSE Aviation | Michael Prkic |
Major Backers & Investors (VSEC)
Notable institutional backers of Vse Corp include T. Rowe Price, SmallCap World Fund Inc, Price (T.Rowe) Associates Inc, according to Nexqual as of June 10, 2026 at 02:24 UTC.
Active Investors
| Investor | Stake |
|---|---|
| T. Rowe Price | 15.39% |
| SmallCap World Fund Inc | 5.68% |
| Price (T.Rowe) Associates Inc | 5.2% |
| Durable Capital Partners Lp | 5.01% |
| UBS Group AG | 3.44% |
| Capital Group | 3.34% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 24.56% |
| Vanguard Group | 10.54% |
| State Street | 9.68% |
| Geode Capital | 2.66% |
Source: Nexqual, June 10, 2026 at 02:24 UTC.
From Vse Corp's Latest SEC 10-K Filing (filed 2026-02-27)
Partnerships
- In addition, the Purchase Agreement provides for up to $125 million in additional contingent earn-out consideration, payable in cash or equity consideration at the Company's sole discretion, based on PAG's 2026 adjusted EBITDA performance.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| DCO | Ducommun Incorporated | USD 156.28 | ▲ 4.26% |
| UTMD | Utah Medical Products, Inc. | USD 68.07 | ▲ 0.62% |
| CASS | Cass Information Systems, Inc | USD 48.35 | ▲ 1.75% |
| FSTR | L.B. Foster Company | USD 42.1 | ▲ 1.41% |
| WEYS | Weyco Group, Inc. | USD 35.92 | ▲ 2.39% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:24 UTC. This page is informational and not investment advice.